{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:17:53Z","timestamp":1768609073108,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/qjmed\/hcz039","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T15:13:26Z","timestamp":1549466006000},"page":"421-427","source":"Crossref","is-referenced-by-count":14,"title":["Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis"],"prefix":"10.1093","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-9662","authenticated-orcid":false,"given":"K","family":"Lapumnuaypol","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Albert Einstein Medical Center, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tiu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Albert Einstein Medical Center, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-3604","authenticated-orcid":false,"given":"C","family":"Thongprayoon","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Mayo Clinic, Nephrology and Hypertension, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-6343","authenticated-orcid":false,"given":"K","family":"Wijarnpreecha","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Mayo Clinic Hospital Jacksonville, Gastroenterology, Jacksonville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ungprasert","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Mayo Clinic, Nephrology and Hypertension, Rochester, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-9711","authenticated-orcid":false,"given":"W","family":"Cheungpasitporn","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, MS, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"2019060307453494100_hcz039-B1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"2019060307453494100_hcz039-B2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"2019060307453494100_hcz039-B3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00423-006-0073-1","article-title":"Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair","volume":"391","author":"Bartsch","year":"2006","journal-title":"Langenbecks Arch Surg"},{"key":"2019060307453494100_hcz039-B4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/ijc.22153","article-title":"What are cyclooxygenases and lipoxygenases doing in the driver\u2019s seat of carcinogenesis?","volume":"119","author":"Furstenberger","year":"2006","journal-title":"Int J Cancer"},{"key":"2019060307453494100_hcz039-B5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"2019060307453494100_hcz039-B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0093-7754(03)00120-9","article-title":"Cyclooxygenase-2 inhibitors in colorectal cancer","volume":"30","author":"Stoehlmacher","year":"2003","journal-title":"Semin Oncol"},{"key":"2019060307453494100_hcz039-B7","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.4049\/jimmunol.0801768","article-title":"Lipopolysaccharide initiates a positive feedback of epidermal growth factor receptor signaling by prostaglandin E2 in human biliary carcinoma cells","volume":"182","author":"Finzi","year":"2009","journal-title":"J Immunol"},{"key":"2019060307453494100_hcz039-B8","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.2005.09.051","article-title":"COX-2: a molecular target for colorectal cancer prevention","volume":"23","author":"Brown","year":"2005","journal-title":"J Clin Oncol"},{"key":"2019060307453494100_hcz039-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.seminoncol.2004.03.045","article-title":"COX-2 inhibition and lung cancer","volume":"31","author":"Sandler","year":"2004","journal-title":"Semin Oncol"},{"key":"2019060307453494100_hcz039-B10","doi-asserted-by":"crossref","first-page":"458.","DOI":"10.1186\/1471-2407-14-458","article-title":"COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis","volume":"14","author":"Pomianowska","year":"2014","journal-title":"BMC Cancer"},{"key":"2019060307453494100_hcz039-B11","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.12659\/MSM.894330","article-title":"Expression and significance of COX-2 and Ki-67 in hepatolithiasis with bile duct carcinoma","volume":"21","author":"Wang","year":"2015","journal-title":"Med Sci Monit"},{"key":"2019060307453494100_hcz039-B12","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2741\/1429","article-title":"Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications","volume":"9","author":"Chu","year":"2004","journal-title":"Front Biosci"},{"key":"2019060307453494100_hcz039-B13","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1007\/s13277-014-2021-y","article-title":"PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression","volume":"35","author":"Jongthawin","year":"2014","journal-title":"Tumour Biol"},{"key":"2019060307453494100_hcz039-B14","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.jss.2008.10.006","article-title":"Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo","volume":"157","author":"Wentz","year":"2009","journal-title":"J Surg Res"},{"key":"2019060307453494100_hcz039-B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000362542","article-title":"A selective cyclooxygenase-2 inhibitor (Etodolac) prevents spontaneous biliary tumorigenesis in a hamster bilioenterostomy model","volume":"52","author":"Kitasato","year":"2014","journal-title":"Eur Surg Res"},{"key":"2019060307453494100_hcz039-B16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"2019060307453494100_hcz039-B17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.humpath.2012.09.004","article-title":"Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma","volume":"44","author":"Aishima","year":"2013","journal-title":"Hum Pathol"},{"key":"2019060307453494100_hcz039-B18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/jcp.2010.080713","article-title":"Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis","volume":"63","author":"Kim","year":"2010","journal-title":"J Clin Pathol"},{"key":"2019060307453494100_hcz039-B19","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-04-2136","article-title":"Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients","volume":"11","author":"Santini","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019060307453494100_hcz039-B20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1440-1746.2003.03299.x","article-title":"Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis","volume":"19","author":"Kim","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"2019060307453494100_hcz039-B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2019060307453494100_hcz039-B22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1158\/1055-9965.EPI-05-0032","article-title":"Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China","volume":"14","author":"Liu","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019060307453494100_hcz039-B23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.28920","article-title":"Aspirin use and risk of cholangiocarcinoma: external validation with big data","volume":"65","author":"Altaii","year":"2017","journal-title":"Hepatology"},{"key":"2019060307453494100_hcz039-B24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10620-014-3056-z","article-title":"Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom","volume":"59","author":"Burr","year":"2014","journal-title":"Dig Dis Sci"},{"key":"2019060307453494100_hcz039-B25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1940-6207.CAPR-15-0126","article-title":"NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project","volume":"8","author":"Petrick","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"2019060307453494100_hcz039-B26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.28529","article-title":"Aspirin use and the risk of cholangiocarcinoma","volume":"64","author":"Choi","year":"2016","journal-title":"Hepatology"},{"key":"2019060307453494100_hcz039-B27","doi-asserted-by":"crossref","first-page":"28.","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"Gonzalez-Perez","year":"2003","journal-title":"BMC Cancer"},{"key":"2019060307453494100_hcz039-B28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","article-title":"Population-wide impact of long-term use of aspirin and the risk for cancer","volume":"2","author":"Cao","year":"2016","journal-title":"JAMA Oncol"},{"key":"2019060307453494100_hcz039-B29","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jhep.2004.07.016","article-title":"Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells","volume":"41","author":"Yoon","year":"2004","journal-title":"J Hepatol"},{"key":"2019060307453494100_hcz039-B30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1053\/gast.2002.32410","article-title":"Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterology"},{"key":"2019060307453494100_hcz039-B31","doi-asserted-by":"crossref","first-page":"G88","DOI":"10.1152\/ajpgi.00539.2003","article-title":"Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth","volume":"287","author":"Ishimura","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2019060307453494100_hcz039-B32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.seminoncol.2004.03.040","article-title":"Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy","volume":"31","author":"Gately","year":"2004","journal-title":"Semin Oncol"},{"key":"2019060307453494100_hcz039-B33","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (part I)","volume":"90","author":"Taketo","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2019060307453494100_hcz039-B34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2016.04.018","article-title":"Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells","volume":"153","author":"Buranrat","year":"2016","journal-title":"Life Sci"},{"key":"2019060307453494100_hcz039-B35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.21873\/anticanres.11296","article-title":"Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-kB","volume":"37","author":"Saengboonmee","year":"2017","journal-title":"Anticancer Res"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/6\/421\/28757352\/hcz039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T07:46:00Z","timestamp":1559547960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/112\/6\/421\/5308610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,2,7]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcz039","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,7]]}}}